Brooks O'Neil
Stock Analyst at Lake Street
(1.88)
# 3,235
Out of 4,996 analysts
36
Total ratings
41.18%
Success rate
-8.89%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $12.00 | - | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $5.20 | +53.85% | 7 | Aug 11, 2025 | |
| LFMD LifeMD | Maintains: Buy | $18 → $14 | $6.43 | +117.73% | 3 | Aug 6, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $9.76 | +104.92% | 2 | Apr 21, 2025 | |
| SRDX Surmodics | Upgrades: Buy | $43 | $29.95 | +43.57% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $84.19 | +30.66% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $19.53 | +53.61% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $28.31 | +150.79% | 1 | Jan 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $10.19 | +155.15% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $47.10 | +16.77% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $15.02 | +19.84% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.10 | +21.95% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.94 | +72.91% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $24.19 | +7.48% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.70 | +1,462.06% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $34.40 | +270.64% | 1 | Sep 15, 2020 |
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $12.00
Upside: -
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $5.20
Upside: +53.85%
LifeMD
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $14
Current: $6.43
Upside: +117.73%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $9.76
Upside: +104.92%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $29.95
Upside: +43.57%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $84.19
Upside: +30.66%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $19.53
Upside: +53.61%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $28.31
Upside: +150.79%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $10.19
Upside: +155.15%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $47.10
Upside: +16.77%
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $15.02
Upside: +19.84%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $4.10
Upside: +21.95%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $6.94
Upside: +72.91%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $24.19
Upside: +7.48%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.70
Upside: +1,462.06%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $34.40
Upside: +270.64%